USPTO serial 86740171
CELLDEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 8, 2016
- Examiner
- TURNER, JASON FITZGERALD
- Law office
- TMEG LAW OFFICE 108
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CELLDEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew Hintz, Esq.
Matthew Hintz, Esq. Lowenstein Sandler LlpOne Lowenstein DriveRoseland, NJ 07068UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Vaccines; Therapeutic vaccines; ] Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; [ Antibody drug conjugates, namely, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the integumentary system and reproductive system; ] Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; ] Therapeutic antibodies and immune system modulators, namely, pharmaceutical preparations for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors, namely, ligands and proteins for stem cells in stem cell mobilization; ] pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, [ immune system stimulators and ] immune system modulators | ACTIVE | Apr 13, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2025 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Nov 3, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 3, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 3, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 8, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 8, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 8, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 23, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 23, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 3, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 20, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 1, 2015 | NWAP | NEW APPLICATION ENTERED | — |